Jianyou Corporation (603707.SH) subsidiary obtained FDA approval for additional production site registration of injectable vecuronium bromide drugs in the United States.

Zhixin Finance APP news, Jianyou Co., Ltd. (603707.SH) announced that its subsidiary Meitheal Pharmaceuticals, Inc. (hereinafter referred to as "Meitheal") recently received approval from the United States Food and Drug Administration (FDA) for the production site of injectable vecuronium bromide, 10mg/bottle and 20mg/bottle (ANDA number: 074688), approving production at the site of Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.